Dow Jones

43 877,21

-0,08%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

NERX

Neorx (NERX)

Neorx (MM)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:NERX

1 2 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
19/06/2006	14h30	PR Newswire (US)	Poniard Pharmaceuticals Announces Name Change Effective and Highlights Targeted Objectives for Picoplatin Clinical Program	NASDAQ:NERX
07/06/2006	15h00	PR Newswire (US)	NeoRx Corporation (Poniard Pharmaceuticals) Announces Participation in Pacific Growth Equities 2006 Life Sciences Growth Confer	NASDAQ:NERX	Neorx (MM)
01/06/2006	15h00	PR Newswire (US)	Onmark Signs Contracts with Two Additional Pharmaceutical Manufacturers and Enrolls 1,800 Members	NASDAQ:NERX
31/05/2006	15h00	PR Newswire (US)	NeoRx Corporation (Poniard Pharmaceuticals) Announces Treatment of First Patient With Picoplatin in Phase 1/2 Front-Line Prosta	NASDAQ:NERX	Neorx (MM)
15/05/2006	23h15	PR Newswire (US)	NeoRx Corporation (Poniard Pharmaceuticals) Reports First Quarter Financial Results	NASDAQ:NERX	Neorx (MM)
10/05/2006	15h00	PR Newswire (US)	NeoRx Initiates Clinical Trial of Picoplatin in Colorectal Cancer and Announces Name Change to Poniard Pharmaceuticals and Relo	NASDAQ:NERX	Neorx (MM)
08/05/2006	15h00	PR Newswire (US)	NeoRx Announces Participation in Upcoming Conferences	NASDAQ:NERX	Neorx (MM)
03/05/2006	15h00	PR Newswire (US)	NeoRx to Host Conference Call on May 10 to Provide Corporate and Picoplatin Clinical Development Updates	NASDAQ:NERX	Neorx (MM)
27/04/2006	15h00	PR Newswire (US)	NeoRx Closes $65 Million Financing Transaction	NASDAQ:NERX	Neorx (MM)
25/04/2006	19h30	PR Newswire (US)	NeoRx Shareholders Approve Financing Transaction	NASDAQ:NERX	Neorx (MM)
25/04/2006	15h00	PR Newswire (US)	NeoRx Expands Picoplatin Lung Cancer Clinical Trial Into Selected Eastern European Countries	NASDAQ:NERX	Neorx (MM)
11/04/2006	19h13	PR Newswire (US)	NeoRx Adjourns Special Meeting of Shareholders	NASDAQ:NERX	Neorx (MM)
08/03/2006	22h55	PR Newswire (US)	NeoRx Corporation's Auditors Expressed Going-Concern Qualification	NASDAQ:NERX	Neorx (MM)
07/03/2006	14h00	PR Newswire (US)	NeoRx Mails Definitive Proxy Statement for Special Shareholder Meeting Set for April 11, 2006	NASDAQ:NERX	Neorx (MM)
01/03/2006	22h15	PR Newswire (US)	NeoRx Reports Fourth Quarter and Full Year Financial Results	NASDAQ:NERX	Neorx (MM)
23/02/2006	14h00	PR Newswire (US)	NeoRx Corporation Regains Compliance With Nasdaq Minimum Bid Listing Requirement	NASDAQ:NERX	Neorx (MM)
02/02/2006	00h10	PR Newswire (US)	NeoRx Signs Definitive Agreement for $65 Million Private Financing	NASDAQ:NERX	Neorx (MM)
12/01/2006	02h00	PR Newswire (US)	NeoRx Receives Notice From Nasdaq Regarding Minimum Bid Price Rule	NASDAQ:NERX	Neorx (MM)
10/11/2005	14h01	PR Newswire (US)	NeoRx Announces Orphan Drug Designation for Picoplatin for Treatment of Small Cell Lung Cancer	NASDAQ:NERX	Neorx (MM)
09/11/2005	22h05	PR Newswire (US)	NeoRx Reports Third Quarter 2005 Financial Results	NASDAQ:NERX	Neorx (MM)
01/11/2005	14h01	PR Newswire (US)	NeoRx to Present at Rodman & Renshaw Techvest Healthcare Conference	NASDAQ:NERX	Neorx (MM)
11/10/2005	15h01	PR Newswire (US)	NeoRx to Present at BIO InvestorForum 2005	NASDAQ:NERX	Neorx (MM)
27/09/2005	23h11	PR Newswire (US)	NeoRx Corporation Regains Compliance with Nasdaq Minimum Bid Listing Requirement	NASDAQ:NERX	Neorx (MM)
09/08/2005	23h18	PR Newswire (US)	NeoRx Reports Second Quarter 2005 Financial Results	NASDAQ:NERX	Neorx (MM)
04/08/2005	14h30	PR Newswire (US)	NeoRx Joins The Scripps Research Institute in First Scientific Collaboration at Scripps Florida	NASDAQ:NERX	Neorx (MM)
11/07/2005	16h56	PR Newswire (US)	NeoRx Announces Treatment of First Patient With Picoplatin in Phase 2 Clinical Trial in Small Cell Lung Cancer	NASDAQ:NERX	Neorx (MM)
27/06/2005	15h00	PR Newswire (US)	NeoRx Appoints David A. Karlin, M.D., as Senior Vice President of Clinical Development and Regulatory Affairs	NASDAQ:NERX	Neorx (MM)
16/06/2005	15h01	PR Newswire (US)	NeoRx CEO to Participate in Break-Out Session at Upcoming BIO 2005 Conference	NASDAQ:NERX	Neorx (MM)
10/05/2005	23h05	PR Newswire (US)	NeoRx Reports First Quarter Financial Results	NASDAQ:NERX	Neorx (MM)
06/05/2005	23h15	PR Newswire (US)	NeoRx Refocusing Resources to Expedite Development of Picoplatin	NASDAQ:NERX	Neorx (MM)